De novo T-lymphocyte responses against baculovirus-derived recombinant influenzavirus hemagglutinin generated by a naive umbilical cord blood model of dendritic cell vaccination

Vaccine

Volumn 27, Issue 10, 2009, Pages 1479-1484

  Safdar, Amar ^a   Decker, William K ^a   Li, Sufang ^a   Xing, Dongxia ^a   Robinson, Simon N ^a   Yang, Hong ^a   Steiner, David ^a   Rodriguez, Gilhen ^a   Shpall, Elizabeth J ^a   Bollard, Catherine ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

Cord blood; Dendritic cell; Influenza; Interferon gamma; T cell response; Vaccine

Indexed keywords

EPITOPE; GAMMA INTERFERON; HEMAGGLUTININ; RECOMBINANT PROTEIN;

ANTIGEN SPECIFICITY; ARTICLE; AUTOTRANSPLANTATION; BACULOVIRUS; CD4+ T LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOTHERAPY; IN VITRO STUDY; INFLUENZA; INFLUENZA VIRUS; LYMPHOCYTE FUNCTION; PRIORITY JOURNAL; PROTEIN BINDING; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; UMBILICAL CORD BLOOD; VACCINATION; VIRUS RECOMBINANT;

BACULOVIRIDAE; DENDRITIC CELLS; FETAL BLOOD; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNITY, CELLULAR; INFANT, NEWBORN; INFLUENZA VACCINES; MODELS, IMMUNOLOGICAL; RECOMBINANT PROTEINS; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 60349103333     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.017     Document Type: Article

References (35)

1. Couch R.B., Englund J.A., and Whimbey E. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med 102 (1997) 2-9
2. Safdar A., and Armstrong D. Infectious morbidity in critically ill patients with cancer. Crit Care Clin 17 (2001) 531-570
3. Lo W., Whimbey E., Elting L., Couch R., Cabanillas F., and Bodey G. Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy. Eur J Clin Microbiol Infect Dis 12 (1993) 778-782
4. Ljungman P., Nahi H., and Linde A. Vaccination of patients with haematological malignancies with one or two doses of influenza vaccine: a randomized study. Br J Haematol 130 (2005) 96-98
5. Safdar A., Alma Rodriguez M., Fayad L.E., Rodriguez G.H., Pro B., Wang M., et al. Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trail in adult patients with non-Hodgkin's B cell lymphoma. J Infect Dis 194 (2006) 1394-1397
6. Safdar A., and Cox M.M.J. Baculovirus-expressed influenza vaccine: a novel technology for safe and expeditious vaccine production for human use. Expert Opin Invest Drugs 16 (2007) 1-8
7. Rezvany M.R., Jeddi-Tehrani M., Biberfeld P., Soderlund J., Mellstedt H., Osterborg A., et al. Dendritic cells in patients with non-progressive B-chronic lymphocytic leukemia have a normal functional capability but abnormal cytokine pattern. Br J Haematol 115 (2001) 263-271
8. Rocha V., Labopin M., Sanz G., Arcese W., Schwerdtfeger R., Bosi A., et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med 351 (2004) 2276-2285
9. Hamza N.S., Lisgaris M., Yadavalli G., Nadeau L., Fox R., Fu P., et al. Kinetics of myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplantation in adults. Br J Haematol 124 (2004) 488-498
10. Figdor C.G., de Vries I.J., Lesterhuis W.J., and Melief C.J. Dendritic cell immunotherapy: mapping the way. Nat Med 10 (2004) 475-480
11. Decker W.K., Xing D., and Shpall E.J. Dendritic cell immunotherapy for the treatment of neoplastic disease. Biol Blood Marrow Transplant 12 (2006) 113-125
12. Parmar S., Robinson S.N., Komanduri K., St John L., Decker W., Xing D., et al. Ex vivo expanded umbilical cord blood T cells maintain naïve phenotype and TCR diversity. Cytotherapy 8 (2006) 149-157
13. Decker W.K., Xing D., Li S., Robinson S.N., Yang H., Yao X., et al. Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help. Vaccine 24 (2006) 3203-3216
14. Decker W.K., and Shpall E.J. Progress in dendritic cell immunotherapy: elucidating the enigma of Th-1 polarization. Hum Vaccine 4 (2008) 162-164
15. Decker WK, Xing D, Li S, Robinson SN, Yang H, Steiner D, et al., Th-1 polarization is regulated by dendritic cell comparison of MHC class I and class II antigens. Blood; in press.
16. Hsu A.K., Kerr B.M., Jones K.L., Lock R.B., Hart D.N., and Rice A.M. RNA loading of leukemic antigens into cord blood-derived dendritic cells for immunotherapy. Biol Blood Marrow Transplant 12 (2006) 855-867
17. + T cell subsets. Clin Exp Immunol 152 (2008) 72-80
18. Bell J.J., Ellis J.S., Guloglu F.B., Tartar D.M., Lee H.H., Divekar R.D., et al. Early effector T cells producing significant IFN-gamma develop into memory. J Immunol 180 (2008) 179-187
19. Rocha B., and Tanchot C. CD8 T cell memory. Semin Immunol 16 (2004) 305-314
20. Hu Y., He Y., Srivenugopal K.S., Fan S., and Jiang Y. In vitro antitumor cytotoxic activity T lymphocyte response induced by dendritic cells transduced with DeltaNp73alpha recombinant adenovirus. Oncol Rep 18 (2007) 1085-1091
21. Guo G., Chen S., Zhang J., Luo L., Yu J., Dong H., et al. Antitumor activity of a fusion of esophageal carcinoma cells and with dendritic cells derived from cord blood. Vaccine 23 (2005) 5225-5230
22. Wang P., Munger C.M., Joshi A.D., Pirruccello S.J., and Joshi S.S. Cytotoxicity of cord blood derived Her2/neu-specific cytotoxic T lymphocytes against human breast cancer in vitro and in vivo. Breast Cancer Res Treat 83 (2004) 15-23
23. Salio M., Dulphy N., Renneson J., Herbert M., McMichael A., Marchant A., et al. Efficient priming of antigen-specific cytotoxic T lymphocytes by human cord blood dendritic cells. Int Immunol 15 (2003) 1265-1273
24. Osman Y., Narita M., Ayres F., Takahashi M., Alldawi L., Tatsuo F., et al. Generation of Ag-specific cytotoxic T lymphocytes by DC transfected with in vitro transcribed influenza virus matrix protein (M1) mRNA. Cytotherapy 5 (2003) 161-168
25. Park K.D., Marti L., Kurtzberg J., and Szabolcs P. In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naïve cord blood lymphocytes. Blood 108 (2006) 1770-1773
26. Rastogi D., Wang C., Mao X., Lendor C., Rothman P.B., and Miller R.L. Antigen-specific immune responses to influenza vaccine in utero. J Clin Invest 117 (2007) 1637-1646
27. Cox R.J., Haaheim L.R., Ericsson J.C., Madhun A.S., and Brokstad K.A. The humoral and cellular responses induced locally and systemically after parenteral influenza vaccination in man. Vaccine 24 (2006) 6577-6580
28. Crowe J.E. The role of antibodies in respiratory viral immunity. Semin Virol 7 (1996) 273-283
29. Neff-LaFord H.D., Vorderstrasse B.A., and Lawrence B.P. Fewer CTL, not enhanced NK cells, are sufficient for viral clearance from the lungs of immunocompromised mice. Cell Immunol 226 (2003) 54-64
30. Boon A.C., de Mutsert G., Fouchier R.A., Osterhaus A.D., and Rimmelzwaan G.F. Functional profile of human influenza virus-specific cytotoxic T lymphocyte activity is influenced by interleukin-2 concentration and epitope specificity. Clin Exp Immunol 142 (2005) 45-52
31. Mbawuike I.N., Fujihashi K., DiFabio S., Kawabata S., McGhee J.R., Couch R.B., et al. Human interleukin-12 enhances interferon-gamma-producing influenza-specific memory CD8+ cytotoxic T lymphocytes. J Infect Dis 180 (1999) 1477-1486
32. Zhang Y., Wang Y., Gilmore X., Xu K., and Mbawuike I.N. Independent and synergistic effects of interleukin-18 and interleukin-12 in augmenting cytotoxic T lymphocyte responses and IFN-γ production in aging. J Interferon Cytokine Res 21 (2001) 843-850
33. Toes R.E., Ossendorp F., Offringa R., and Melief C.J. CD4 T cells and their role in antitumor immune responses. J Exp Med 189 (1999) 753-756
34. Boon A.C., Fringuelli E., Graus Y.M., Fouchier R.A., Sintnicholaas K., Iorio A.M., et al. Influenza A virus specific T cell immunity in humans during aging. Virology 299 (2002) 100-108
35. Zhang Y., Wang Y., Gilmore X., Xu K., Chen M., Tebebi P., et al. Apoptosis and reduced influenza A virus specific CD8+ T cells in ageing mice. Cell Death Differ 9 (2002) 651-660